Skip to main content
. Author manuscript; available in PMC: 2013 Oct 30.
Published in final edited form as: Am J Hypertens. 2011 Feb 10;24(5):10.1038/ajh.2011.12. doi: 10.1038/ajh.2011.12

Figure 2.

Figure 2

The effect of 16 weeks of placebo or vitamin D treatment on A) flow-mediated dilation, B) shear rate area under the curve (AUC), and C) flow-mediated dilation normalized for shear rate. *Significant from vitamin D at baseline. †Significant from placebo at 16 weeks.